• Lineage Cell Therapeutics to Report Second Quarter 2022 Financial Results and Provide Business Update on August 11, 2022

    3 days ago - By San Diego Biotechnology

    CARLSBAD, Calif.--- $LCTX LineageCellTherapeutics-Lineage Cell Therapeutics, Inc. , a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that it will report its second quarter 2022...
    Read more ...

     

  • Poseida Therapeutics Announces Proposed Public Offering of Common Stock

    3 days ago - By San Diego Biotechnology

    SAN DIEGO, Aug. 4, 2022 /PRNewswire/ - Poseida Therapeutics, Inc. , a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform technologies to create cell and gene therapeutics with the capacity to cure, today announced...
    Read more ...